Current through Reg. 49, No. 38; September 20, 2024
(a) General. A person who engages in the wholesale distribution of
prescription drugs in this state for use in humans is exempt from this subchapter if the person is exempt
under:
(1) the Prescription Drug Marketing Act of 1987 (PDMA Act), (21
United States Code (USC) §353(c)(3)(B));
(2) the regulations
adopted by the secretary to administer and enforce the PDMA Act;
(3) the interpretations of the PDMA Act set forth in the compliance policy
manual of the United States Food and Drug Administration; or
(4)
the Texas Occupations Code §562.154.
(b)
Exemptions from licensing. Persons who engage in the following types of distribution of prescription drugs
are exempt from the licensing requirements of this subchapter, to the extent it does not violate provisions
of the Texas Controlled Substances Act, Texas Health and Safety Code Chapter 481, or the Texas Dangerous Drug
Act, Texas Health and Safety Code Chapter 483:
(1) intracompany sales of
prescription drugs, which means transactions or transfers of prescription drugs between a division,
subsidiary, parent, or affiliated or related company under common ownership and control, or any transaction
or transfer between co-license holders of a co-licensed product;
(2) the sale, purchase, trade, or transfer of prescription drugs or the
offer to sell, purchase, trade, or transfer a prescription drug for emergency medical reasons; including a
transfer of a prescription drug by a retail pharmacy to another retail pharmacy to alleviate a temporary
shortage;
(3) the distribution of prescription drug samples by a
representative of a manufacturer;
(4) the return of drugs by a
hospital, health care entity, or charitable institution in accordance with Title 21, Code of Federal
Regulations (CFR) §203.23;
(5) the sale of reasonable
quantities by a retail pharmacy of a prescription drug to a licensed practitioner for office use;
(6) the sale, purchase, or trade of a drug, an offer to sell, purchase, or
trade a drug, or the dispensing of a drug under a prescription;
(7) the sale, transfer, merger, or consolidation of all or part of the
business of a pharmacy from or with another pharmacy, whether accomplished as a purchase and sale of stock or
business assets;
(8) the delivery of, or offer to deliver, a
prescription drug by a common carrier solely in the common carrier's usual course of business of transporting
prescription drugs, if the common carrier does not store, warehouse, or take legal ownership of the
prescription drug;
(9) the sale or transfer from a retail
pharmacy or pharmacy warehouse of expired, damaged, returned, or recalled prescription drugs to the original
manufacturer or to a third-party returns processor in accordance with procedures set out in
21 CFR §
203.23(a)(1) -
(5) for returns;
(10) the
purchase or other acquisition by a hospital or other health care entity that is a member of a group
purchasing organization of a drug for its own use from the group purchasing organization or from other
hospitals or health care entities that are members of such organizations;
(11) the sale, purchase, or trade of a drug or an offer to sell, purchase,
or trade a drug by a charitable organization described in the Internal Revenue Code of 1986,
26 USC §
501(c)(3), to a nonprofit affiliate of the organization to
the extent otherwise permitted by law;
(12) the sale, purchase,
or trade of a drug or an offer to sell, purchase, or trade a drug among hospitals or other health care
entities that are under common control; for purposes of this subchapter, common control means the power to
direct or cause the direction of the management and policies of a person or an organization, whether by
ownership of stock, voting rights, contract, or otherwise; or
(13) the sale, purchase, or trade of blood and blood components intended
for transfusion.
(c) Applicability of other
requirements. An exemption from the licensing requirements granted in subsection (b) of this section does not
constitute an exemption from other applicable requirements for prescription drugs under this subchapter or
under the Texas Food, Drug, and Cosmetic Act, Health and Safety Code, Chapter 431.
(d) Exemption from certain requirements for certain wholesale distributors.
(1) A wholesale distributor that distributes only prescription drugs that
are medical gases is exempt from the following requirements: §
229.424(d) of this subchapter (relating to
Licensure Requirements), §229.425(b)(4) - (5), (c) and (d) of this subchapter (relating to Licensing
Procedures); and §
229.424(n) and §
229.425(h) of this subchapter concerning
bonds.
(2) A wholesale distributor that is a manufacturer or a
third-party logistics provider on behalf of a manufacturer is exempt from the following requirements: §
229.424(d) of this title; §229.425(b)(4) -
(5), (c) and (d) of this subchapter; and §
229.424(n) and §
229.425(h) of this subchapter concerning
bonds.
(3) A state agency or a political subdivision of this
state that distributes prescription drugs using federal or state funding to nonprofit health care facilities
or local intellectual and developmental disability authorities, referred to as local mental health or mental
retardation authorities, for distribution to a pharmacy, practitioner, or patient is exempt from
§229.424(d) and (n) and §
229.425(d) and (h) of this subchapter
concerning bonds, and §
229.429(f) of this subchapter (relating to
Minimum Standards of Licensure) concerning pedigree.
(4) The
executive commissioner of the Texas Health and Human Services Commission by rule may exempt specific
purchases of prescription drugs by state agencies and political subdivisions of this state if the executive
commissioner determines the requirements of this subchapter would result in a substantial cost to the state
or a political subdivision of the state.